{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T02:45:49Z","timestamp":1774665949976,"version":"3.50.1"},"reference-count":36,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T00:00:00Z","timestamp":1457308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Qingkailing injection (QKLI) is a modern Chinese medicine preparation derived from a well-known classical formulation, An-Gong-Niu-Huang Wan. Although the clinical efficacy of QKLI has been well defined, its severe adverse drug reactions (ADRs) were extensively increased. Through thorough attempts to reduce ADR rates, it was realized that the effect-based rational use plays the key role in clinical practices. Hence, the pharmacokinetic-pharmacodynamic (PK-PD) model was introduced in the present study, aiming to link the pharmacokinetic profiles with the therapeutic outcomes of QKLI, and subsequently to provide valuable guidelines for the rational use of QKLI in clinical settings. The PK properties of the six dominant ingredients in QKLI were compared between the normal treated group (NTG) and the pyrexia model group (MTG). Rectal temperatures were measured in parallel with blood sampling for NTG, MTG, model control group (MCG), and normal control group (NCG). Baicalin and geniposide exhibited appropriate PK parameters, and were selected as the PK markers to map the antipyretic effect of QKLI. Then, a PK-PD model was constructed upon the bacalin and geniposide plasma concentrations vs. the rectal temperature variation values, by a two-compartment PK model with a Sigmoid Emax PD model to explain the time delay between the drug plasma concentration of PK markers and the antipyretic effect after a single dose administration of QKLI. The findings obtained would provide fundamental information to propose a more reasonable dosage regimen and improve the level of individualized drug therapy in clinical settings.<\/jats:p>","DOI":"10.3390\/molecules21030317","type":"journal-article","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T10:25:00Z","timestamp":1457346300000},"page":"317","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Pharmacokinetic-Pharmacodynamic Modeling to Study the Antipyretic Effect of Qingkailing Injection on Pyrexia Model Rats"],"prefix":"10.3390","volume":"21","author":[{"given":"Zhixin","family":"Zhang","sequence":"first","affiliation":[{"name":"School of Chinese Pharmacy, Beijing University of Chinese Medicine, South of Wangjing Middle Ring Road, Chaoyang District, Beijing 100102, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Qin","sequence":"additional","affiliation":[{"name":"School of Chinese Pharmacy, Beijing University of Chinese Medicine, South of Wangjing Middle Ring Road, Chaoyang District, Beijing 100102, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Peng","sequence":"additional","affiliation":[{"name":"School of Chinese Pharmacy, Beijing University of Chinese Medicine, South of Wangjing Middle Ring Road, Chaoyang District, Beijing 100102, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Chinese Pharmacy, Beijing University of Chinese Medicine, South of Wangjing Middle Ring Road, Chaoyang District, Beijing 100102, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Chinese Pharmacy, Beijing University of Chinese Medicine, South of Wangjing Middle Ring Road, Chaoyang District, Beijing 100102, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Lu","sequence":"additional","affiliation":[{"name":"School of Chinese Pharmacy, Beijing University of Chinese Medicine, South of Wangjing Middle Ring Road, Chaoyang District, Beijing 100102, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuelin","family":"Song","sequence":"additional","affiliation":[{"name":"Modern Research Center for Traditional Chinese Medicine, Beijing University of Chinese Medicine, No. 11 North Third Ring Road, Chaoyang District, Beijing 100029, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8219-1370","authenticated-orcid":false,"given":"Xiaoyan","family":"Gao","sequence":"additional","affiliation":[{"name":"School of Chinese Pharmacy, Beijing University of Chinese Medicine, South of Wangjing Middle Ring Road, Chaoyang District, Beijing 100102, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2016,3,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.chroma.2005.07.066","article-title":"An approach to develop two-dimensional fingerprint for the quality control of Qingkailing injection by high-performance liquid chromatography with diode array detection","volume":"1090","author":"Yan","year":"2005","journal-title":"J. Chromatogr. A."},{"key":"ref_2","unstructured":"The State Pharmacopoeia Commission of the P.R. China (2010). Pharmacopoeia of the P.R. China, Chemical Industry Press."},{"key":"ref_3","unstructured":"Gao, X.Y. (2006). Study on the methods of online process monitoring and quality control of Qingkailing injection. [Master\u2019s Thesis, Beijing University of Chinese Medicine]."},{"key":"ref_4","first-page":"904","article-title":"Study on the method of rapid quality control of aqueous solution of flos Ionicerae japonicae extraction in the preparation of Qingkailing injection","volume":"26","author":"Gao","year":"2006","journal-title":"Spectrosc. Spect. Anal."},{"key":"ref_5","first-page":"1673","article-title":"Characterization and determination of nitrogen in preparation of Qingkailing injection and its intermediate products","volume":"33","author":"Gao","year":"2008","journal-title":"China J. Tradit. Chin. Med. Pharm."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Gao, X.Y., Guo, M.X., Peng, L., Zhao, B.S., Su, J.K., Liu, H.Y., Zhang, L., Bai, X., and Qiao, Y.J. (2013). UPLC Q-TOF\/MS-based metabolic profiling of urine reveals the novel antipyretic mechanisms of Qingkailing injection in a rat model of yeast-induced pyrexia. Evid. Based Complement. Altern. Med.","DOI":"10.1155\/2013\/864747"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1002\/jssc.201400339","article-title":"A metabolomic strategy to screen the prototype components and metabolites of Qingkailing injection in rat urine by high-performance liquid chromatography with tendem mass spectrometry","volume":"37","author":"Guo","year":"2014","journal-title":"J. Sep. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/bmc.3077","article-title":"A rapid and sensitive UPLC-MS\/MS method for quantification of two caffeoylquinic acids and four main active components in rat plasma after an intravenous administration of Qingkailing injection and its application to a pharmacokinetic study","volume":"28","author":"Peng","year":"2013","journal-title":"Biomed. Chromatogr."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zhang, L., Wang, X., Su, J.K., Liu, H.Y., Zhang, Z.X., Qin, L.L., He, C., Peng, L., Guo, M.X., and Gao, X.Y. (2014). One single amino acid for estimation the content of total free amino acids in Qingkailing injection using high-performance liquid chromatography-diode array detection. J. Anal. Methods Chem.","DOI":"10.1155\/2014\/951075"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.yrtph.2009.06.008","article-title":"Comments on serious anaphylaxis caused by nine Chinese herbal injections used to treat common colds and upper respiratory tract infections","volume":"55","author":"Ji","year":"2009","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2885.2004.00613.x","article-title":"Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine","volume":"27","author":"Toutain","year":"2004","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1128\/AAC.47.2.626-635.2003","article-title":"Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids","volume":"47","author":"Aliabadi","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_13","first-page":"1926","article-title":"Study of pharmacokinetics\/pharmacodynamics of levofloxacin","volume":"85","author":"Zhang","year":"2005","journal-title":"Natl. Med. J. China"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1128\/AAC.00711-05","article-title":"Integration of pharmacokinetic and pharmacodynamic indices of Marbofloxacin in turkeys","volume":"50","author":"Haritova","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","article-title":"Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: A dose-ranging, randomized trial. The cyclosporine a phase 2 study group","volume":"107","author":"Stevenson","year":"2000","journal-title":"Ophthalmology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/oby.2003.102","article-title":"A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity","volume":"11","author":"Bray","year":"2003","journal-title":"Obes. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.21778","article-title":"The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial","volume":"54","author":"Emery","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0447.2005.00660.x","article-title":"Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression","volume":"113","author":"Freeman","year":"2006","journal-title":"Acta. Psychiatr. Scand."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1365-2885.2001.00304.x","article-title":"A pharmacokinetic\/pharmacodynamic approach vs. a dose titration for the determination of a dosage regimen: The case of nimesulide, a Cox-2 selective nonsteroidal anti-inflammatory drug in the dog","volume":"24","author":"Toutain","year":"2001","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1211\/0022357021779131","article-title":"Pharmacokinetic-pharmacodynamic modelling of insulin: Comparison of indirect pharmacodynamic response with effect-compartment link models","volume":"54","author":"Lin","year":"2002","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.vascn.2005.01.002","article-title":"Applicability of microdialysis as a technique for pharmacokinetic-pharmacodynamic (PK-PD) modeling of antihypertensive beta-blockers","volume":"52","author":"Diverniero","year":"2005","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.vascn.2008.03.002","article-title":"Comparison of different pharmacodynamic models for PK-PD modeling of verapamil in renovascular hypertension","volume":"57","author":"Bertera","year":"2008","journal-title":"J. Pharmacol. Toxi. Methods"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejphar.2008.02.005","article-title":"Using pharmacokinetic-pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics","volume":"584","author":"Olsen","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1211\/jpp.61.01.0011","article-title":"Increased sensitivity to diltiazem hypotensive effect in an experimental model of high-renin hypertension","volume":"61","author":"Bertera","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_25","first-page":"555","article-title":"Adverse effect and mechanism of chlorogenic acid in clearing heat and detoxication traditional Chinese medicine injections","volume":"7","author":"Li","year":"2009","journal-title":"Chin. J. Mod. Appl. Pharm."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/01480540903580055","article-title":"Role of chlorogenic acid in the toxicity induced by Chinese herbal injections","volume":"33","author":"Li","year":"2010","journal-title":"Drug Chem. Toxicol."},{"key":"ref_27","first-page":"912","article-title":"Effect of chlorogenic acid on degranulation in mast cell RBL-2H3","volume":"36","author":"Peng","year":"2011","journal-title":"China J. Chin. Mater. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0531-5565(90)90019-X","article-title":"Body temperature rhythms, cold tolerance, and fever in young and old rats of both genders","volume":"25","author":"Refinetti","year":"1990","journal-title":"Exp. Gerontol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0378-8741(03)00175-2","article-title":"Antipyretic properties of the aqueous and ethanol extracts of the leaves of Ocimum suave and Ocimum lamiifolium in mice","volume":"88","author":"Makonnen","year":"2003","journal-title":"J. Ethnopharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0367-326X(03)00057-1","article-title":"Anti-inflammatory, analgesic and antipyretic properties of Clitoria ternatearoot","volume":"74","author":"Devi","year":"2003","journal-title":"Fitoterapia"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejphar.2005.01.048","article-title":"Interaction between inhibitors of inducible nitric oxide synthase and cyclooxygenase in Brewer\u2019s yeast induced pyrexia in mice: An isobolographic study","volume":"511","author":"Bhat","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jtherbio.2010.05.011","article-title":"Antipyretic effects of the aqueous, ethyl acetate and hexane leaf extracts of Ficus exasperata (Moraceae) in mice","volume":"35","author":"Bafor","year":"2010","journal-title":"J. Therm. Biol."},{"key":"ref_33","first-page":"107","article-title":"High-performance liquid chromatographic determination of baicalin in human plasma","volume":"17","author":"Wang","year":"2000","journal-title":"J. Shenyang Pharm. Univ."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/bmc.655","article-title":"Determination of human plasma protein binding of baicalin by ultrafiltration and high-performance liquid chromatography","volume":"20","author":"Tang","year":"2006","journal-title":"Biomed. Chromatogr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-198106060-00002","article-title":"Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models","volume":"6","author":"Holford","year":"1981","journal-title":"Clin. Pharmacokinet."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/ps040438","article-title":"Pharmacokinetic\/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine","volume":"4","author":"Toutain","year":"2002","journal-title":"AAPS PharmSci."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/21\/3\/317\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:20:17Z","timestamp":1760210417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/21\/3\/317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,7]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3]]}},"alternative-id":["molecules21030317"],"URL":"https:\/\/doi.org\/10.3390\/molecules21030317","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,7]]}}}